(c) 2024 PillSync.com

Canada imatinib 400 mg

INDICATIONS & USAGE: unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans...systemic mastocytosis (ASM) without the D816V c-Kit mutation...blast crisis (BC), accelerated phase (AP), or in chronic phase...adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia...kinase inhibitor...


4 years ago   oval brown N I 400 score Canada imatinib 400 mg

oval brown N I 400 score

Comments

Related Pills

imatinib 400 MG Oral Tablet

american health packaging

imatinib mesylate tablet film coated

aurobindo pharma limited

imatinib tablet

dr.reddy's laboratories inc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site